Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Therapeutic combinations of RAR antagonists and RXR agonists and use thereof

US Patent 6653322 · Granted Nov 25, 2003

Estimated economic value: $52,297,000

Assignee

Inventors

View full patent text on Google Patents →